This is a prospective cohort study designed to investigate the range of metabolic abnormalities observed in patients living with HIV on antiretroviral therapy. This study will also explore the concurrent role of poor oral health in supporting and driving chronic immune activation and inflammation in HIV infection.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Dental Caries as assessed by DMFS Score
Timeframe: Baseline
Dental Caries as assessed by DMFS Score
Timeframe: 6 months after baseline visit
Dental Caries as assessed by DMFS Score
Timeframe: 12 months after baseline visit
Dental Caries as assessed by DMFS Score
Timeframe: 18 months after baseline visit
Dental Caries as assessed by DMFS Score
Timeframe: 24 months after baseline visit
Periodontal disease
Timeframe: Baseline
Periodontal disease
Timeframe: 12 months after baseline visit
Periodontal disease
Timeframe: 24 months after baseline visit
Osteopenia as assessed by DXA scan findings
Timeframe: Baseline
Osteopenia as assessed by DXA scan findings
Timeframe: 24 months after baseline visit
Quality of life as assessed by the Xerostomia Quality of Life Scale (XeQoLS)
Timeframe: Baseline
Quality of life as assessed by the Xerostomia Quality of Life Scale (XeQoLS)
Timeframe: 12 months after baseline visit
Quality of life as assessed by the Xerostomia Quality of Life Scale (XeQoLS)
Timeframe: 24 months after baseline visit
Quality of life as assessed by the Oral Health Related Quality of Life (OHRQoL)
Timeframe: Baseline
Quality of life as assessed by the Oral Health Related Quality of Life (OHRQoL)
Timeframe: 12 months after baseline visit
Quality of life as assessed by the Oral Health Related Quality of Life (OHRQoL)
Timeframe: 24 months after baseline visit
Quality of life as assessed by the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool
Timeframe: Baseline
Quality of life as assessed by the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool
Timeframe: 12 months after baseline visit
Quality of life as assessed by the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool
Timeframe: 24 months after baseline visit